Inhibitors
Inhibitors are molecules that bind to enzymes, receptors, or other proteins to reduce or block their biological activity. These compounds are widely used in research to study biological pathways, understand disease mechanisms, and develop therapeutic drugs. Inhibitors play a crucial role in the treatment of various diseases, including cancer, cardiovascular diseases, and infections. At CymitQuimica, we provide a diverse range of high-quality inhibitors to support your research in biochemistry, cell biology, and pharmaceutical development.
Subcategories of "Inhibitors"
- Angiogenesis(2,539 products)
- Apoptosis(5,812 products)
- Cell Cycle/Checkpoint(4,460 products)
- Chromatin/Epigenetics(2,245 products)
- Cytoskeletal Signaling(1,381 products)
- DNA Damage/DNA Repair(2,829 products)
- Endocrinology/Hormones(3,517 products)
- Enzyme(3,640 products)
- GPCR/G-Protein(8,357 products)
- Immunology and Inflammation(3,538 products)
- Influenza Virus(296 products)
- JAK/STAT signaling(405 products)
- MAPK Signaling(1,203 products)
- Membrane Transporter/Ion Channel(2,806 products)
- Metabolism(9,456 products)
- Microbiology/Virology(6,998 products)
- Neuroscience(9,938 products)
- Other Inhibitors(37,853 products)
- Oxidation-Reduction(40 products)
- PI3K/Akt/mTOR Signaling(1,399 products)
- Proteases/Proteasome(1,600 products)
- Stem Cell and Derivatives(831 products)
- Tyrosine Kinase/Adaptors(2,016 products)
- Ubiquitination(1,650 products)
Show 16 more subcategories
Found 66626 products of "Inhibitors"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Bleomycin Free Base
CAS:<p>Bleomycin Free Base, a glycopeptide antibiotic, halts DNA function and treats solid tumors.</p>Formula:C55H84N17O21S3Color and Shape:SolidMolecular weight:1415.55M826
<p>M826, a non-peptide, potent, selective, and reversible caspase-3 inhibitor, exhibits an IC50 of 0.005 μM and demonstrates strong anti-apoptotic activity in</p>Formula:C28H45N7O6Purity:98%Color and Shape:SolidMolecular weight:575.7Luffolide
CAS:<p>Luffolide, a Luffariella sponge metabolite, shares manoalide's anti-inflammatory traits and fully inhibits PLA2's cleavage of phosphatidylcholine.</p>Formula:C27H40O6Color and Shape:SolidMolecular weight:460.60Rubropunctatin
CAS:<p>Rubropunctatin is a monascus pigment with very potent cancer cell proliferation inhibitory effects.</p>Formula:C21H23NO4Color and Shape:SolidMolecular weight:353.41AL 6598
CAS:<p>AL 6598, a prodrug of PGD2 agonist AL 6556, reduces IOP by 53% at 1μg twice daily in monkeys; binds DP receptors with Ki of 3.2μM.</p>Formula:C23H39ClO5Color and Shape:SolidMolecular weight:431.01F 14679
CAS:<p>F 14679 is a potent 5-HT1A agonist (pKi=10.23) with a maximum Ca2t response similar to 5-HT.</p>Formula:C21H25ClF2N4OPurity:99.09%Color and Shape:SolidMolecular weight:422.9Anticancer agent 68
CAS:<p>Compound 12, an anticancer agent, halts G2/M phase, triggers cell death, and activates p53 & PTEN for tumor suppression.</p>Formula:C20H18ClNO5Color and Shape:SolidMolecular weight:387.81Cas9-IN-1
<p>Cas9-IN-1 is a potent inhibitor of Cas9 with an IC50 value of 7.02 μM. Cas9-IN-1 acts by binding apo-Cas9 and blocking the formation of the Cas9:gRNA complex.</p>Formula:C17H11Cl2F3N2O3SColor and Shape:SolidMolecular weight:451.25AK-295
CAS:<p>AK 295, also known as CX 295, is a dipeptide inhibitor of alpha-ketoamide calpain.</p>Formula:C26H40N4O6Color and Shape:SolidMolecular weight:504.62MRS-2339
CAS:<p>MRS-2339 is a P2X receptor activator.</p>Formula:C12H15ClN5O6PColor and Shape:SolidMolecular weight:391.70BRD-K98645985
CAS:<p>BRD-K98645985: BAF inhibitor, binds ARID1A, reverses HIV-1 latency, EC50 ~2.37μM, alters nucleosome placement.</p>Formula:C33H43N5O4Purity:98%Color and Shape:SolidMolecular weight:573.73DNA crosslinker 2 dihydrochloride
CAS:<p>Potent DNA crosslinker 2 binds minor groove, increases Tm by 1.2°C, and inhibits NCI-H460, A2780, MCF-7 cancer cells.</p>Formula:C15H22Cl2N8OColor and Shape:SolidMolecular weight:401.29Antibacterial agent 113
<p>Antibacterial agent 113 targets multiple bacteria including P. aeruginosa and E. coli, showing efficacy at MIC 15625 μM.</p>Formula:C29H18ClN5OColor and Shape:SolidMolecular weight:487.94Imolamine hydrochloride
CAS:<p>Imolamine hydrochloride is a blood platelet aggregation antagonist.</p>Formula:C14H21ClN4OColor and Shape:SolidMolecular weight:296.80Ophiobolin C
CAS:<p>inhibitor of human CCR5 binding to HIV-1 gp120</p>Formula:C25H38O3Purity:98%Color and Shape:SolidMolecular weight:386.57Steroid sulfatase/17β-HSD1-IN-1
<p>Steroid sulfatase/17β-HSD1-IN-1 is a highly effective inhibitor of both steroid sulfatase and 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) activities,</p>Formula:C19H18N2O5SColor and Shape:SolidMolecular weight:386.42BI-207524
CAS:<p>BI-207524 is a novel NS5B Thumb Pocket 1 Inhibitor with Improved Potency for the Potential Treatment of Chronic Hepatitis C Virus Infection.</p>Formula:C35H36ClN5O5Color and Shape:SolidMolecular weight:642.14PrCP-7414
CAS:<p>PrCP-7414 is a potent PrCP inhibitor, CAS# 1252037-41-4, named after the CAS number's last four digits.</p>Formula:C31H33Cl2N5O2Color and Shape:SolidMolecular weight:578.53MDL-100173
CAS:<p>MDL-100173 is a dual angiotensin-converting enzyme (ACE)/neutral endopeptidase (NEP) inhibitor.</p>Formula:C24H26N2O4SColor and Shape:SolidMolecular weight:438.54PF-06263276
CAS:<p>PF-06263276 selectively inhibits pan-JAK with IC50: JAK1 (2.2 nM), JAK2 (23.1 nM), JAK3 (59.9 nM), TYK2 (29.7 nM).</p>Formula:C31H31FN8O2Purity:98%Color and Shape:SolidMolecular weight:566.63Adecypenol
CAS:<p>Adecypenol is a unique adenosine deaminase inhibitor. It shows effective inhibitory activity against calf intestinal adenosine deaminase.</p>Formula:C12H16N4O4Purity:98%Color and Shape:SolidMolecular weight:280.28CARM1-IN-3 dihydrochloride
<p>CARM1-IN-3 dihydrochloride (17b) is a potent CARM1 inhibitor (IC50: 0.07 μM) with selectivity over CARM3 (IC50 >25 μM).</p>Formula:C24H34Cl2N4O2Color and Shape:SolidMolecular weight:481.46Streptothricin F
CAS:<p>Streptothricin F is a biochemical.</p>Formula:C19H34N8O8Color and Shape:SolidMolecular weight:502.52LY2934747
CAS:<p>LY2934747 is a novel, potent, and systemically bioavailable mGlu2/3 receptor agonist, exhibiting both antipsychotic and analgesic properties in vivo.</p>Formula:C10H13NO4Color and Shape:SolidMolecular weight:211.21Aristoforin
CAS:<p>Aristoforin is a SIRT1 and SIRT2 inhibitor that induces cell cycle arrest, shows potent antitumor effects, and inhibits lymphangiogenesis in vivo.</p>Formula:C37H54O6Color and Shape:SolidMolecular weight:594.82Daeatal
CAS:<p>Dynorphin A ethylamide (1-9), the opioid activities were examined in the bioassays.</p>Formula:C56H93N19O10Purity:98%Color and Shape:SolidMolecular weight:1192.46PD 135158
CAS:PD 135158 is a CCK2 receptor antagonist.Formula:C42H61N5O11Purity:98%Color and Shape:SolidMolecular weight:811.96MAO A/HDAC-IN-1
<p>MAO A/HDAC-IN-1 is an effective monoamine oxidase A (MAO A) and HDAC dual inhibitor, which can be used for glioma research.</p>Formula:C21H24ClN3O3Color and Shape:SolidMolecular weight:401.89Neuraminidase-IN-11
<p>Neuraminidase-IN-11 (15e) inhibits H1N1 (IC50: 4.7nM), H5N1 (8.46nM), H5N8 viruses (1.5nM) selectively & potently.</p>Color and Shape:SolidLTD4 antagonist 1
CAS:<p>LTD4 antagonist 1 is a potent and orally active antagonist of leukotriene D4 (LTD4; Ki: 0.57 nM).</p>Formula:C31H32F3N3O5SPurity:98%Color and Shape:SolidMolecular weight:615.66MC2652
<p>MC2652, a potent LSD1 inhibitor, suppresses leukemia (MV4-11, NB4) and impedes prostate cancer (LNCaP) cell growth.</p>Formula:C22H20N2OColor and Shape:SolidMolecular weight:328.41PptT-IN-2
<p>PptT-IN-2 inhibits PptT enzyme crucial in tuberculosis, with 2.5 μM IC50, showing potential in TB research.</p>Formula:C22H29N5O2Color and Shape:SolidMolecular weight:395.5JAK1-IN-9
CAS:<p>JAK1-IN-9 (compound 23a) is a potent, selective inhibitor of JAK1, demonstrating an IC50 of 72 nM.</p>Formula:C16H13IN6Color and Shape:SolidMolecular weight:416.22STA-1474
CAS:<p>STA-1474, a soluble prodrug of ganetespib (STA-9090), becomes a strong HSP90 inhibitor effective against canine tumors.</p>Formula:C20H21N4O6PColor and Shape:SolidMolecular weight:444.38RX 809055AX
CAS:<p>RX 809055AX is a long lasting opioid antagonist at mu and delta receptors.</p>Formula:C29H29ClN2O4Color and Shape:SolidMolecular weight:505EGFR-IN-62
<p>EGFR-IN-62: IC50 of 10-242 nM for various EGFR mutations, blocks A549/H1975 cell cycle, induces apoptosis, and inhibits cell motility and proliferation.</p>Formula:C30H33N9O2Color and Shape:SolidMolecular weight:551.64Dinordrin
CAS:Dinordrin is an implantation inhibitor and hormone.Formula:C27H36O4Purity:98%Color and Shape:SolidMolecular weight:424.57ROS1-IN-1
<p>ROS1-IN-1, a potent ROS1 kinase inhibitor, has an IC50 of 0.097 μM.</p>Formula:C17H15ClN6SColor and Shape:SolidMolecular weight:370.86CP-199330
CAS:<p>CP-199330: non-toxic alternative to Zafirlukast & Pranlukast, blocks cysteyl LT1 receptors.</p>Formula:C28H24ClF3N2O6SColor and Shape:SolidMolecular weight:609.01ZIKV-IN-5
<p>ZIKV-IN-5 is an acid-stable, low cytotoxic anti-ZIKV agent with an EC50 value of 0.71 μM. ZIKV-IN-5 showed effective inhibition of ZIKV NS5 MTase activity.</p>Formula:C36H45NO4SiColor and Shape:SolidMolecular weight:583.83Dehydrocrenatidine
CAS:<p>Dehydrocrenatidine (Kumujian G) is an inhibitor of JAK and induces cell apoptosis.</p>Formula:C15H14N2O2Purity:98%Color and Shape:SolidMolecular weight:254.28Saussureamine C
CAS:<p>Saussureamine C is an inhibitor of H274Y and N294S mutants.</p>Formula:C19H26N2O5Color and Shape:SolidMolecular weight:362.42TX2-121-1
CAS:<p>TX2-121-1 targets HER3 for proteasome-mediated degradation to inhibit HER3-dependent signalling and growth.</p>Formula:C42H52N8O3Purity:98%Color and Shape:SolidMolecular weight:716.91U 75875
CAS:<p>U 75875 is a protease inhibitor.</p>Formula:C45H61N7O7Color and Shape:SolidMolecular weight:812.01BU09059
CAS:BU09059 is a potent, selective, short-acting antagonist of the κ-opioid receptor (KOR).Formula:C28H37N3O5Purity:98%Color and Shape:SolidMolecular weight:495.61NTPDase-IN-3
CAS:<p>NTPDase-IN-3 inhibits NTPDase1/2/3/8 (IC50: 0.21/1.07/0.38/0.05 μM), useful for cancer and thrombosis research.</p>Formula:C22H24ClN3OS2Color and Shape:SolidMolecular weight:446.03HIV-1 protease-IN-6
<p>HIV-1 protease-IN-6 (17d) strongly inhibits HIV-1 protease (IC50: 21 pM, Ki: 4.7 pM) and effectively targets DRV-resistant mutants.</p>Formula:C27H31FN2O6SColor and Shape:SolidMolecular weight:530.61Piperazinomycin
CAS:<p>Piperazinomycin is an antifungal antibiotic, showing inhibitory activity against fungi and yeasts, especially against Trichophyton.</p>Formula:C18H20N2O2Color and Shape:SolidMolecular weight:296.36Dexnebivolol
CAS:<p>Dexnebivolol (R67138), a ß-adrenergic antagonist, is Nebivolol's enantiomer with β1 blocking and vasodilation properties.</p>Formula:C22H25F2NO4Color and Shape:SolidMolecular weight:405.43FXIa-IN-8
<p>FXIa-IN-8: potent FXIa blocker (IC50: 14.2 nM), anti-thrombotic, low bleeding/toxicity risk.</p>Color and Shape:SolidCOX-2/PI3K-IN-2
<p>COX-2/PI3K-IN-2 (5f): anti-inflammatory & anti-cancer, selectively inhibits COX-2 (Ki=3.02nM), potently blocks PI3K (IC50=2.78nM).</p>Formula:C16H17N5O2Color and Shape:SolidMolecular weight:311.34HDAC6-IN-13
<p>HDAC6-IN-13: potent, selective HDAC6 inhibitor; oral; IC50=0.019μM; targets HDAC1/2/3; crosses blood-brain barrier; anti-inflammatory.</p>Formula:C23H22N4OColor and Shape:SolidMolecular weight:370.45GSK5852
<p>GSK5852, an HCV NS5B inhibitor, has IC50 of 50 nM; potently fights HCV with EC50 of 3.0 nM for GT1a and 1.7 nM for GT1b.</p>Formula:C27H27BF2N2O6SColor and Shape:SolidMolecular weight:556.39DC-U4106
CAS:<p>DC-U4106: USP8 inhibitor, Kd 4.7μM, IC50 1.2μM, degrades Erα, low-toxicity tumor suppressor for breast cancer research.</p>Formula:C29H27N5O5Color and Shape:SolidMolecular weight:525.56RAD51-IN-5
CAS:<p>RAD51-IN-5 blocks RAD51; may aid mitochondrial disorder research. (WO2021164746A1, cmpd 3)</p>Formula:C26H38N4O5S2Color and Shape:SolidMolecular weight:550.73KRAS G12C inhibitor 46
CAS:<p>KRAS G12C inhibitor 46 is a potent inhibitor of KRAS G12C.</p>Formula:C32H33F2N7O2Color and Shape:SolidMolecular weight:585.65CDK8-IN-9
<p>CDK8-IN-9, potent CDK8 inhibitor (IC50: 48.6 nM), curbs tumor growth, useful for colorectal cancer research.</p>Color and Shape:SolidODN 21158
CAS:<p>ODN 21158 is a potent, non-cytotoxic inhibitor of G-modified TLR3 and TLR9. ODN 21158 dose-dependently inhibits IFN-α secretion.</p>Color and Shape:SolidGNE-431
CAS:<p>GNE-431: potent, selective noncovalent Btk inhibitor, IC50=3.2 nM; effective against C481R, T474I, T474M mutants, may counter ibrutinib resistance.</p>Formula:C30H32N10O2Color and Shape:SolidMolecular weight:564.64ONL-1204
CAS:<p>ONL-1204 is a small molecule, CD95 antigen inhibitor (Fas inhibitor) being developed by ONL Therapeutics for the treatment of retinal detachment.</p>Formula:C71H100N18O16Color and Shape:SolidMolecular weight:1461.66Samuraciclib hydrochloride hydrate
<p>Samuraciclib (CT7001) is a potent oral CDK7 inhibitor (IC50: 41 nM) with anti-breast cancer properties.</p>Formula:C22H35ClN6O3Color and Shape:SolidMolecular weight:521.7AS2521780
CAS:AS2521780 is an inhibitor of PKCθ (IC50: 0.48 nM).Formula:C30H41N7OSPurity:98%Color and Shape:SolidMolecular weight:547.76HDAC2-IN-1
<p>HDAC2-IN-1 is an oral HDAC2 inhibitor (IC50: 0.5 μM), crosses the blood-brain barrier, and inhibits HDAC1 and HDAC8.</p>Formula:C22H23ClN4OSColor and Shape:SolidMolecular weight:426.96Macitentan (n-butyl analogue)
CAS:<p>Macitentan n-butyl analogue, an oral ETA/ETB receptor blocker, may treat IPF and PAH.</p>Formula:C20H21Br2N5O4SPurity:98%Color and Shape:SolidMolecular weight:587.29MEK1/2-IN-2
<p>MEK1/2-IN-2 is a potent, ATP-competitive MEK1/2 inhibitor that exhibits equal inhibitory effects on wild-type MEK1/2 and a group of MEK1/2 mutant cells.</p>Formula:C28H22ClFN6OColor and Shape:SolidMolecular weight:512.97Acetylpepstatin
CAS:<p>Acetylpepstatin is an inhibitor of HIV-1 protease, HIV-2 protease, aspartyl protease.</p>Formula:C33H61N5O11Purity:98%Color and Shape:SolidMolecular weight:703.875CaMKIIα-IN-1
<p>CaMKIIα-IN-1 (Compound 4d) is an orally active inhibitor of Ca 2+ /calmodulin-dependent protein kinase II α (CaMKIIα) with a Kd of 219 nM for CaMKIIα WT hub.</p>Formula:C14H11ClO4Color and Shape:SolidMolecular weight:278.69NK1 receptor antagonist 2
CAS:<p>NK1 Receptor Antagonist 2, a compound targeting the NK1 receptor, holds potential for tinnitus and hearing loss research.</p>Formula:C31H35F7N4O2Color and Shape:SolidMolecular weight:628.62PRMT5-IN-1 hydrochloride
<p>PRMT5 IN-1 hydrochloride is a potent PRMT5 inhibitor (IC50: 11 nM), forms covalent adduct with C449, and converts to an aldehyde in vivo.</p>Formula:C19H20Cl2N4O5Color and Shape:SolidMolecular weight:455.29Kahweol linoleate
CAS:<p>Kahweol linoleate, a semi-synthetic from coffee, blocks osteoclast creation, fights cancerous cells, prevents DNA damage, and reduces oxidative stress.</p>Formula:C38H56O4Color and Shape:SolidMolecular weight:576.85hCAII-IN-4
CAS:hCAII-IN-4 (Compound 12j) is a potent inhibitor of human carbonic anhydrase II (hCA II), exhibiting an inhibitory concentration (IC50) of 7.78 μM.Formula:C31H23NO9Color and Shape:SolidMolecular weight:553.52C-di-IMP
CAS:<p>Cyclic-di-IMP (C-di-IMP), a STING agonist, serves as a research tool in tumor studies.</p>Formula:C20H22N8O14P2Color and Shape:SolidMolecular weight:660.38PRMT5-IN-1
CAS:<p>PRMT5-IN-1 is a covalent inhibitor of protein arginine methyltransferase 5 (PRMT5)(IC50 of 11 nM for PRMT5/MEP50).</p>Formula:C19H19ClN4O5Purity:98%Color and Shape:SolidMolecular weight:418.83S1P1 agonist 4
CAS:<p>S1P1 agonist 4 exhibits enhanced potency with an EC 50 value of less than 0.05 mg/kg and a predicted human half-life (t1/2) of approximately 5 days, indicating</p>Formula:C24H31NO3Color and Shape:SolidMolecular weight:381.51Antitumor agent-37
<p>Antitumor agent-37: strong anti-growth, anti-spread, induces DNA damage, apoptosis via Bcl-2/Bax/caspase3, boosts immune response.</p>Formula:C16H18Cl2N2O4PtColor and Shape:SolidMolecular weight:568.32MEN-10354
CAS:<p>MEN-10354 is a less potent and less selective NK-2 tachykinin receptor antagonist compared to the linear analog, R 396.</p>Formula:C37H46N8O9Color and Shape:SolidMolecular weight:746.81GPX4-IN-3
CAS:<p>GPX4-IN-3 (26a) is a potent GPX4 inhibitor, inducing selective ferroptosis with 71.7% inhibition at 1 μM.</p>Formula:C29H24ClN3O3SColor and Shape:SolidMolecular weight:530.04Anti-inflammatory agent 6
<p>Anti-inflammatory agent 6 blocks IKKα/β, IκBα, and NF-κB p65 phosphorylation, key to controlling inflammation.</p>Formula:C22H20O12Color and Shape:SolidMolecular weight:476.39Antibacterial agent 80
<p>Antibacterial agent 80 (compound 20) has antibacterial activity [1].</p>Formula:C14H21N3S2Color and Shape:SolidMolecular weight:295.47Gallinamide A
CAS:Gallinamide A is a potent inhibitor of cathepsin L with an IC 50 value of 17.6 pM.Formula:C31H52N4O7Color and Shape:SolidMolecular weight:592.77Cbl-b-IN-1
CAS:Cbl-b-IN-1 is a potent Cbl-b inhibitor (IC50 <100 nM) with potential anticancer activity for the study of intestinal inflammation.Formula:C29H34N6O2Purity:99.68%Color and Shape:SolidMolecular weight:498.631CS-003 Free base
CAS:<p>CS-003: Triple neurokinin receptor antagonist; Ki=2.3 nM (NK1), 0.54 nM (NK2), 0.74 nM (NK3); treats respiratory diseases.</p>Formula:C34H38Cl2N2O6SPurity:98%Color and Shape:SolidMolecular weight:673.65CLK1/2-IN-1
CAS:<p>CLK1/2-IN-1 is a CLK1 and CLK2 inhibitor and it also inhibits SRPK1 and SRPK2.</p>Formula:C21H20F3N7OPurity:98%Color and Shape:SolidMolecular weight:443.423-IN-PP1
CAS:<p>3-IN-PP1: PKD inhibitor (IC50: 94-108 nM for PKD1/2/3), broad anticancer agent for research.</p>Formula:C17H18N6Color and Shape:SolidMolecular weight:306.36Antitumor agent-42
<p>Antitumor agent-42 inhibits microtubule multimerisation and NO release, exhibiting anti-angiogenic, colony-forming and apoptosis-inducing effects.</p>Formula:C24H19BrN2O8SColor and Shape:SolidMolecular weight:575.39MA242 free base
CAS:<p>MA242 free base is a dual MDM2/NFAT1 inhibitor that triggers apoptosis in pancreatic cancer cells.</p>Formula:C24H20ClN3O3SColor and Shape:SolidMolecular weight:465.95DMP-728 free base
CAS:<p>DMP-728 free base is a highly potent and selective GPIIbDIIa antagonist</p>Formula:C25H36N8O7Color and Shape:SolidMolecular weight:560.60FAPI-74
CAS:<p>FAPI-74 is a PET (positron emission tomography) tracer involved in early FAPI-PET imaging.FAPI-74 can be used to study cancer tumors and degenerative diseases.</p>Formula:C36H49N9O8Color and Shape:SolidMolecular weight:735.83DMP 728
CAS:<p>DMP 728 is an antagonist of Glycoprotein IIb-IIIa.</p>Formula:C26H40N8O10SPurity:98%Color and Shape:SolidMolecular weight:656.71Topoisomerase I/II inhibitor 3
<p>Topoisomerase I/II inhibitor 3 suppresses cell growth and induces apoptosis in liver cancer by blocking PI3K/Akt/mTOR.</p>Formula:C24H24N2O4Color and Shape:SolidMolecular weight:404.46CB30865
CAS:CB30865 (ZM 242421) is a selective and highly effective nicotinamide phosphoribosyltransferase (Nampt) inhibitor with potential antitumor activity.Formula:C26H22BrN5O2Purity:99.04%Color and Shape:SolidMolecular weight:516.39ART615
<p>ART615 is a related isomer of ART558. ART615 inhibits Polθ by <10% at 12 μM and is able to act as a control for ART558 (IC50:7.9 nM).</p>Formula:C21H21F3N4O2Color and Shape:SolidMolecular weight:418.41Calcipotriol Impurity C
CAS:<p>Calcipotriol Impurity C is the impurity of Calcipotriol. Calcipotriol is a VDR-like receptors ligand.</p>Formula:C27H40O3Purity:98%Color and Shape:SolidMolecular weight:412.614MRK003
CAS:<p>MRK003, a γ-secretase inhibitor, induces apoptosis, halts cell growth in myeloma/NHL, and affects notch signaling and PI3K/Akt pathway.</p>Formula:C25H31F6N3O2SColor and Shape:SolidMolecular weight:551.59CEP-2563
CAS:CEP-2563 is a prodrug of CEP-751. It also used as an antitumor agent, inhibiting protein kinases.Formula:C36H41ClN6O6Purity:98%Color and Shape:SolidMolecular weight:689.20SCP1-IN-2
<p>SCP1-IN-2: potent, selective SCP1 inhibitor; induces REST degradation, hinders its activity, may study REST-driven glioblastoma growth.</p>Formula:C19H17F3N2O6S2Color and Shape:SolidMolecular weight:490.47(S)-Butaprost free acid
CAS:<p>(S)-Butaprost (free acid) is a potent and highly selective EP2 receptor agonist[1].</p>Formula:C23H38O5Color and Shape:SolidMolecular weight:394.54RORγt inverse agonist 29
<p>RORγt inverse agonist 29 is a potent, selective, orally active RORγt inverse agonist with an IC50 value of 21 nM.</p>Formula:C25H24N2O5SColor and Shape:SolidMolecular weight:464.53TAS-117 hydrochloride
<p>TAS-117 HCl: potent oral Akt inhibitor (Akt1 IC50: 4.8nM, Akt2: 1.6nM, Akt3: 44nM), boosts anti-myeloma effects, induces cell death.</p>Formula:C26H25ClN4O2Color and Shape:SolidMolecular weight:460.96PD-1/PD-L1-IN-16
<p>PD-1/PD-L1-IN-16 is a potent inhibitor of PD-1/PD-L1 (IC50: 53.2 nM) and has shown research potential for tumour immunotherapy.</p>Formula:C34H30N4O4Color and Shape:SolidMolecular weight:558.63Antibacterial synergist 1
<p>Compound 20P is a potent antibacterial, inhibits biofilms with IC50 4.5 μM, and reduces pyocyanin at IC50 8.6 μM.</p>Formula:C19H24N2O4Color and Shape:SolidMolecular weight:344.4YM158 free base
CAS:<p>YM158 free base is a potent and selective antagonist of TXA2 and LTD4 receptor (pA2s: about 8.81 and 8.87).</p>Formula:C32H33ClN6O5S2Purity:98%Color and Shape:SolidMolecular weight:681.22UTPγS trisodium salt
CAS:<p>P2Y2 and P2Y4 receptor agonist</p>Formula:C9H12N2Na3O14P3SPurity:98%Color and Shape:SolidMolecular weight:566.15COX-2-IN-29
<p>COX-2-IN-29 is a selective inhibitor of orally active COX-2 (IC50: 0.005 μM).</p>Formula:C22H23FN2O6S2Color and Shape:SolidMolecular weight:494.56FK-3657
CAS:<p>FK-3657 is a non-peptide antagonist of bradykinin (BK)-B2 receptor.</p>Formula:C30H27Cl2N5O4Color and Shape:SolidMolecular weight:592.47LSD1-IN-19
<p>LSD1-IN-19 is a potent, selective LSD1 inhibitor with Ki of 0.108 μM and 72h IC50 values of 0.17-0.40 μM.</p>Formula:C33H42N6O2Color and Shape:SolidMolecular weight:554.73Hsp90-IN-16
<p>Hsp90-IN-16, a selective HSP90 inhibitor, targets HER2+ cancers with 6 μM IC50 in HCC1954 cells, blocking client proteins and inducing apoptosis.</p>Formula:C30H26FN3O6Color and Shape:SolidMolecular weight:543.54GLS-1-IN-1
<p>GLS-1-IN-1 (compound 1d) is a GLS-1 inhibitor that inhibits Hep G2, MCF 7 and MCF 10A cells.</p>Formula:C26H25FN4OSColor and Shape:SolidMolecular weight:460.57PI3Kα-IN-8
<p>PI3Kα-IN-8 is a selective inhibitor of PI3Kα (IC50: 0.012 μM).</p>Formula:C26H27BrN4O2Color and Shape:SolidMolecular weight:507.42Antibacterial agent 118
<p>Antibacterial agent 118, potent against various mycobacteria, has MIC values ranging from 10.2 to 163.0 μM. Useful in TB research.</p>Formula:C19H21N5O2SColor and Shape:SolidMolecular weight:383.47Lp-PLA2-IN-5
CAS:<p>Lp-PLA2-IN-5 inhibits Lp-PLA2 and PAF-AH, potentially useful in Alzheimer's and atherosclerosis studies.</p>Formula:C23H18F5N3O4Color and Shape:SolidMolecular weight:495.4Agosterol A
CAS:<p>Agosterol A is isolated from marine sponge Spongia.</p>Formula:C33H52O8Color and Shape:SolidMolecular weight:576.76Antiangiogenic agent 3
<p>Antiangiogenic agent 3 blocks HUVEC cell migration, chemotaxis, and lowers Src, cdc42, MAPK gene expression.</p>Formula:C19H20O7Color and Shape:SolidMolecular weight:360.36Tuberculosis inhibitor 4
<p>TB inhibitor 4, a spirothiazolidinone from mandelic acid, blocks 98% of M. tuberculosis H37Rv under 6 μg/mL.</p>Formula:C23H26N2O3SColor and Shape:SolidMolecular weight:410.53PGDM
CAS:<p>PGD2 is involved in allergy, asthma, sleep, temperature regulation, inhibits clotting, and relaxes blood vessels; PGDM, its metabolite, is a biomarker.</p>Formula:C16H24O7Color and Shape:SolidMolecular weight:328.36α-Amylase-IN-1
CAS:<p>α-Amylase-IN-1 is an α-Amylase inhibitor (IC50: 0.5509 μM).</p>Formula:C18H18N2O3Purity:99.92%Color and Shape:SoildMolecular weight:310.35TD-0212
CAS:TD-0212: Oral dual antagonist for AT1 (pKi 8.9) & NEP inhibitor (pIC50 9.2).Formula:C28H34FN3O4SPurity:98%Color and Shape:SolidMolecular weight:527.65Naldemedine tosylate
CAS:<p>Naldemedine (S-297995) tosylate, a PAMORA, targets μ-, δ-, κ-opioid receptors, aiding OIC research, may bind to SARS-CoV2's 3CL pro.</p>Formula:C39H42N4O9SColor and Shape:SolidMolecular weight:742.84Kri 1314
CAS:Kri 1314 is a cyclohexyl-norstatine-containing dipeptide renin inhibitor which has potential for the treatment of hypertension.Formula:C38H51N5O7Color and Shape:SolidMolecular weight:689.84MIF2-IN-1
<p>MIF2-IN-1, potent inhibitor of MIF2 (IC50: 1μM), halts non-small cell lung cancer growth via MAPK pathway.</p>Formula:C26H19F3N2O2SColor and Shape:SolidMolecular weight:480.5JAK3-IN-13
<p>JAK3-IN-13: Oral JAK3 inhibitor, selective & potent. Acts on NK1, JNK2, JNK3, Tyk2. Anti-tumor. IC50: JNK3, 8 nM; Tyk2, 365 nM; JNK2, 2039 nM; NK1, 4728 nM.</p>Formula:C25H33ClN6O5Color and Shape:SolidMolecular weight:533.02Elongation factor P-IN-1
<p>EFP-IN-1: potent β-lysine derivative, inhibits EFP, slows E. coli growth.</p>Formula:C14H31N3O2Color and Shape:SolidMolecular weight:273.41MK2-IN-4
CAS:<p>MK2-IN-4 is a MAPKAPK2 (MK2) inhibitor (IC50: 45 nM). MK2-IN-4 can be used in cancer, inflammation and immunology studies.</p>Formula:C25H24N4O2Color and Shape:SolidMolecular weight:412.48QPX7728 bis-acetoxy methyl ester
CAS:<p>QPX7728 bis-acetoxy methyl ester is an inhibitor of boronic acid β-lactamase.</p>Formula:C15H14BFO8Purity:98%Color and Shape:SolidMolecular weight:352.08Alkyne-probe 1
<p>Alkyne-probe 1 is usually used as an Alkyne-labeled fluorescent or chemical probe.</p>Formula:C14H23N5O2Purity:98%Color and Shape:SolidMolecular weight:293.36COX-2-IN-8
<p>COX-2-IN-8 (Compound 6a) is a potent, selective, orally active COX-2 inhibitor (IC50: 6.585 μM) with a higher COX-2 selectivity than Celecoxib.</p>Formula:C19H19N3O4S2Color and Shape:SolidMolecular weight:417.5RET-IN-1
CAS:<p>RET-IN-1 is a RET kinase inhibitor (IC50s: 1 nM, 7 nM, and 101 nM for RET (WT), RET (V804M) , and RET (G810R), respectively).</p>Formula:C29H31N9O3Purity:98%Color and Shape:SolidMolecular weight:553.61sEH inhibitor-2
<p>SEH inhibitor-2 is an orally active sEH blocker (IC50=0.9 nM) with predicted 71.2-88.4% absorption, potentially aiding cardiovascular health.</p>Formula:C23H18N4O3Color and Shape:SolidMolecular weight:398.41BSc5367
CAS:<p>BSc5367 inhibits Nek1 kinase (IC50: 11.5 nM), key in cell cycle, DNA repair, impacting ALS, PKD, cancer.</p>Formula:C20H15N3O2Color and Shape:SoildMolecular weight:329.35CCR1 antagonist 11 hydrochloride
<p>Oral CCR1 antagonist A1B1 targets h/m/rCCR1 (IC50: 0.03/0.58/0.32 μM), potential for treating inflammatory diseases.</p>Color and Shape:SolidFGFR-IN-5
CAS:<p>FGFR-IN-5 is a potent inhibitor of FGFR. FGFR-IN-5 has potential for research in cancer diseases.</p>Formula:C25H22N6O3Color and Shape:SolidMolecular weight:454.48JAK1/TYK2-IN-3
<p>JAK1/TYK2-IN-3, orally active, selectively inhibits TYK2 (IC50: 6 nM), JAK1 (37 nM), JAK2 (140 nM), JAK3 (362 nM), and has anti-inflammatory effects.</p>Color and Shape:SolidYKL-05-093
CAS:<p>YKL-05-093 is a alt inducible kinase (SIK) inhibitor. YKL-05-093 increases bone formation and bone mass.</p>Formula:C35H40N6O4Color and Shape:SolidMolecular weight:608.73(3S,4R)-Tofacitinib
CAS:(3S,4R)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib is a JAK3 inhibitor(IC50 : 1 nM).Formula:C16H20N6OPurity:98%Color and Shape:SolidMolecular weight:312.37AZD-4121 tert-butylammonium
CAS:<p>AZD-4121 tert-butylammonium is an oral cholesterol absorption inhibitor targeting NPC1L1 for the treatment of dyslipidaemia.</p>Formula:C40H50F2N4O7SColor and Shape:SolidMolecular weight:768.91Antifungal agent 19
<p>Antifungal agent 19 shows the potent antifungal activity ( EC 50 = 0.72 μM).</p>Formula:C19H18F4O2Color and Shape:SolidMolecular weight:354.34Mibefradil dihydrochloride hydrate
CAS:<p>Mibefradil dihydrochloride hydrate is a long-acting antihypertensive blocking high-voltage L calcium channels.</p>Formula:C29H42Cl2FN3O4Color and Shape:SolidMolecular weight:586.57NS2B/NS3-IN-3
CAS:<p>NS2B/NS3-IN-3 (Compd 66) is an inhibitor of Flavivirus NS2B-NS3 protease [1] .</p>Formula:C19H21N3O2Color and Shape:SolidMolecular weight:323.39HR-546
CAS:<p>HR-546 is a prostaglandin E2 and prostaglandin F2alpha antagonist.</p>Formula:C26H44O6Color and Shape:SolidMolecular weight:452.62Samuraciclib
CAS:<p>Samuraciclib (CT7001) is an oral CDK7 inhibitor with 41 nM IC50, notable for its high selectivity and potency against breast cancer cells.</p>Formula:C22H30N6OColor and Shape:SolidMolecular weight:394.51Massarilactone H
CAS:<p>Massarilactone H, a polyketide, is a neuraminidase inhibitor, with an IC 50 of 8.18 µM .</p>Formula:C11H12O5Color and Shape:SolidMolecular weight:224.21DN-F01
<p>DN-F01 exhibits a potent calcium-dependent inhibitory effect on cardiac myofibrillar ATPase activity, with an IC50 of 11 ± 4 nmol/L.</p>Formula:C22H16N2O2Color and Shape:SolidMolecular weight:340.37Antiviral agent 7
<p>Antiviral agent 7 is a peptide-based coating that kills viruses.</p>Formula:C29H31F2N3O6Color and Shape:SolidMolecular weight:555.57Oleuroside
CAS:<p>Oleuroside can protect against mitochondrial dysfunction in models of early Alzheimer's disease and brain ageing.</p>Formula:C25H32O13Purity:98%Color and Shape:SolidMolecular weight:540.51VGD071
CAS:<p>VGD071, a compound that targets sortilin, presents a promising avenue for forthcoming research utilizing mouse models of breast cancer.</p>Formula:C32H41N3O4S2Color and Shape:SolidMolecular weight:595.82Aurora/LIM kinase-IN-1
<p>Aurora/LIM kinase-IN-1 (Compound F114) is a dual inhibitor targeting aurora and lim kinases, potentially useful in GBM cancer treatment efforts.</p>Formula:C16H20N6OColor and Shape:SolidMolecular weight:312.37AChE/BChE-IN-3 hydrochloride
<p>AChE/BChE-IN-3 (BMC-1) HCl is a dual inhibitor with IC50s: eqBChE 0.383 μM, elAChE 6.08 μM.</p>Formula:C15H25ClN2O3Color and Shape:SolidMolecular weight:316.82Equisetin
CAS:<p>Equisetin: a QSI from Fusarium equiseti, curbs P. aeruginosa virulence, fights Gram-positive bacteria & HIV-1 integrase; not antibacterial to Gram-negative.</p>Formula:C22H31NO4Purity:98%Color and Shape:SolidMolecular weight:373.49Lumirubin
CAS:<p>Lumirubin is a water-soluble photoproduct of bilirubin formed in vivo during phototherapy.</p>Formula:C33H36N4O6Color and Shape:SolidMolecular weight:584.66ST362
CAS:<p>ST362, an anticancer agent, acts by disrupting DNA repair and halting growth in prostate, colon, lung and breast cancer cells.</p>Formula:C25H21NO6SPurity:98%Color and Shape:SolidMolecular weight:463.5EGFR/HER2-IN-4
<p>EGFR/HER2-IN-4: oral, irreversible dual EGFR inhibitor (IC50: 0.6 nM), targets L858R/T790M mutations, potent anti-lung cancer effects in vivo.</p>Color and Shape:SolidTLR7/8 antagonist 1
<p>Compound 16c, an imidazoquinoline, is a TLR7/8 agonist; IC50: 3.91 μM (TLR7), 2.19 μM (TLR8); targets TLR-2050 for disease treatment.</p>Formula:C24H27N5O2Color and Shape:SolidMolecular weight:417.5NB-533
CAS:<p>NB-533 is a macrocyclic peptidic BACE-1 inhibitor.</p>Formula:C33H55N3O4Color and Shape:SolidMolecular weight:557.81CEP-7055
CAS:<p>CEP-18770: oral proteasome inhibitor; blocks NF-kappaB; may cause cancer cell apoptosis; less toxic than bortezomib in normal cells.</p>Formula:C32H35N3O4Color and Shape:SolidMolecular weight:525.64HCV-IN-7
CAS:HCV-IN-7: potent oral HCV NS5A inhibitor, pan-genotypic, IC50s 3-47 pM, good pharmacokinetics, favorable liver uptake.Formula:C40H48N8O6SPurity:98%Color and Shape:SolidMolecular weight:768.92NBD-10007
CAS:NBD-10007 is an inhibitor of HIV-1 entry.Formula:C20H25ClN4O3SPurity:98%Color and Shape:SolidMolecular weight:436.96XY153
<p>XY153 (8l) is a BD2 selective BET inhibitor targeting BRD4, 3 & 2 with IC50s: 0.79, 5.31 & 5.09 nM, useful in acute myeloid leukemia & cancer research.</p>Formula:C33H34FN3O4Color and Shape:SolidMolecular weight:555.64ACT-777991
CAS:<p>ACT-777991: oral CXCR3 blocker, stable in microsomes/hepatocytes, inhibits T-cell migration to CXCL11.</p>Formula:C20H20F6N8O2SColor and Shape:SolidMolecular weight:550.48GSK2945 hydrochloride
<p>GSK2945 HCl is a specific Rev-erbα antagonist, EC50: 21.5 μM (mouse), 20.8 μM (human), increases cholesterol 7α-hydroxylase.</p>Formula:C20H19Cl3N2O2SColor and Shape:SolidMolecular weight:457.8QTX125 TFA
<p>QTX125 TFA: Potent, selective HDAC6 inhibitor with antitumor effects.</p>Formula:C25H20F3N3O7Color and Shape:SolidMolecular weight:531.44OSI-7904L free acid
CAS:<p>OSI-7904L is a folate-based thymidylate synthase inhibitor. It also has antimalarial and antitumor properties.</p>Formula:C27H24N4O6Purity:98%Color and Shape:SolidMolecular weight:500.5GDC-0339
CAS:GDC-0339: oral Pim kinase inhibitor for multiple myeloma (Kis: Pim1 - 0.03 nM, Pim2 - 0.1 nM, Pim3 - 0.02 nM), well-tolerated.Formula:C20H22F3N7OSColor and Shape:SolidMolecular weight:465.5Motuporin
CAS:<p>Motuporin is an inhibitor of type-1 and type-2A protein phosphatase catalytic subunits (PP-1c and PP-2Ac).</p>Formula:C40H57N5O10Color and Shape:SolidMolecular weight:767.91LJ-4517
<p>LJ-4517 is an effective A2AAR antagonist (Ki=18.3 nM). LJ-4517 can effectively replace the binding of [3H] ZM241385 at WT A2AAR.</p>Formula:C19H21N5O3SColor and Shape:SolidMolecular weight:399.47GS-9822
CAS:<p>GS-9822 is a new LEDGIN inhibitor targeting LEDGF/p75 to alter HIV integration, showing a block-and-lock effect in cells.</p>Formula:C36H39ClN4O4SColor and Shape:SolidMolecular weight:659.24DS88790512
CAS:<p>DS88790512, IC50 at 11 nM, is an effective, selective, oral bioeffective TRPC6 inhibitor.</p>Formula:C22H29N3O2Purity:98%Color and Shape:SolidMolecular weight:367.48PF-4693627
CAS:<p>PF-4693627 is an effective and selective microsomal prostaglandin E synthase-1 inhibitor (IC50=3 nM).</p>Formula:C26H29Cl2N3O3Purity:98%Color and Shape:SolidMolecular weight:502.43CDK-IN-9
<p>CDK-IN-9: A potent CDK inhibitor, gels to enhance CDK12/DDB1 binding, targets CDK2/E (IC50: 4 nM), induces apoptosis via dephosphorylation.</p>Formula:C21H24N8SColor and Shape:SolidMolecular weight:420.53Purine phosphoribosyltransferase-IN-1
<p>Compound (S,R)-48 inhibits Pf, Pv, & Tbr PRT with Ki of 50, 20, 2 nM.</p>Formula:C11H15N5Na4O10P2Color and Shape:SolidMolecular weight:531.17Enprostil
CAS:<p>Enprostil: synthetic PGE2 analog, reduces gastric acid, protects mucosa, lowers post-meal gastrin, treats ulcers effectively and safely.</p>Formula:C23H28O6Purity:98%Color and Shape:SolidMolecular weight:400.462',5,7-Trihydroxy-8-methoxyflavanone
CAS:<p>2',5,7-Trihydroxy-8-methoxyflavanone has cytotoxic activity.</p>Formula:C16H14O6Purity:98%Color and Shape:SolidMolecular weight:302.28PAT-347
CAS:<p>PAT-347 is a potent inhibitor of Autotaxin, an enzyme linked to cell survival and diseases like cancer and fibrosis.</p>Formula:C28H21ClF2N2O3SColor and Shape:SolidMolecular weight:538.99CB2 receptor antagonist 1
CAS:<p>Compound 29 is a potent, CB2-selective antagonist/reverse agonist. Derivatives 23 & 24 offer antinociception; 24 activates cannabinoid/TRPV1 receptors.</p>Formula:C28H47NO3Color and Shape:SolidMolecular weight:445.68GSK 932121
CAS:<p>GSK 932121: potent antimalarial, targets P. falciparum by inhibiting cytochrome bc1 in the electron transport chain.</p>Formula:C20H15ClF3NO4Purity:98%Color and Shape:SolidMolecular weight:425.79EGFR-IN-24
<p>EGFR-IN-24 is a potent inhibitor of EGFR and inhibits EGFR (del19/T790M/C797S) and EGFR (L858R/T790M/C797S).</p>Formula:C30H35FN6O3Color and Shape:SolidMolecular weight:546.64Falecalcitriol
CAS:<p>Falecalcitriol is an analog of calcitriol. It has a higher potency both in vivo and in vitro systems, which is longer duration of action in vivo.</p>Formula:C27H38F6O3Purity:98%Color and Shape:SolidMolecular weight:524.58ADP-2341
<p>ADP-2341 is a soluble analog of FiVe1.</p>Formula:C24H29Cl2N5O3Color and Shape:SolidMolecular weight:506.43Tubulin polymerization-IN-4
CAS:<p>Tubulin polymerization-IN-4: inhibits tubulin (IC50=4.6 μM), blocks G2/M phase, induces apoptosis, hinders cell cloning/migration, damages vasculature.</p>Formula:C21H21ClN2O4Color and Shape:SolidMolecular weight:400.86VEGFR-2-IN-15
<p>VEGFR-2-IN-15 (Compound 14b) is a potent inhibitor of VEGFR-2. VEGFR-2-IN-15 inhibits the growth of HepG2 cells in the Pre-G1 phase and induces apoptosis.</p>Formula:C23H18ClN3O4SColor and Shape:SolidMolecular weight:467.92BPTF-IN-BZ1
<p>BPTF-IN-BZ1 is a BPTF inhibitor that possesses a high potency with a Kd of 6.3 nM.</p>Formula:C13H15ClN4OColor and Shape:SolidMolecular weight:278.74SLC4101431
<p>SLC4101431 is a potent SphK2 inhibitor with Ki value of 90 nM.</p>Formula:C29H28ClN7OSColor and Shape:SolidMolecular weight:558.1RDN2150
CAS:<p>RDN2150 (Compound 25), a ZAP-70 inhibitor with an IC50 of 14.6 nM, covalently binds to the C346 residue of ZAP-70, suppressing the expression of CD25 and CD69</p>Formula:C28H29ClN8O4Color and Shape:SolidMolecular weight:577.03LHC-165
CAS:LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors.Formula:C29H32F2N3O7PPurity:98%Color and Shape:SolidMolecular weight:603.55XP5
<p>XP5 is an oral HDAC6 inhibitor, potent against cancer cells, including YCC3/7 (IC50=31 nM to 2.31 μM).</p>Formula:C19H25N3O5SColor and Shape:SolidMolecular weight:407.48Cap-dependent endonuclease-IN-6
CAS:<p>Cap-dependent endonuclease-IN-6 (compound 13) is a Cap-dependent endonuclease (CEN) inhibitor that inhibits influenza virus.</p>Formula:C23H21N3O3SColor and Shape:SolidMolecular weight:419.5Etamicastat
CAS:<p>Etamicastat can be used in the research of cardiovascular diseases.</p>Formula:C14H15F2N3OSPurity:98%Color and Shape:SolidMolecular weight:311.35Mu opioid receptor antagonist 3
<p>Potent, selective MOR antagonist (compound 26); crosses blood-brain barrier. Ki: 0.24 nM, EC50: 0.54 nM; for studying OUD.</p>Formula:C25H28N2O4SColor and Shape:SolidMolecular weight:452.57TAS05567
CAS:<p>TAS05567 is a potent, highly selective, and ATP-competitive Syk inhibitor (IC50: 0.37 nM).</p>Formula:C21H29N9O2Purity:98%Color and Shape:SolidMolecular weight:439.51Xeruborbactam
CAS:<p>QPX7728 is an of ultra-broad-spectrum boronic acid beta-lactamase.</p>Formula:C10H8BFO4Purity:98%Color and Shape:SolidMolecular weight:221.98Antifungal agent 17
<p>Antifungal agent 17 showed good antifungal activity against B. cinerea (EC50: 2.86 μg/mL).</p>Formula:C18H16Br2O2Color and Shape:SolidMolecular weight:424.13GSK2578999A
CAS:<p>GSK2578999A is a betulin derivative with antitumor activity.</p>Formula:C46H62ClNO7Purity:98%Color and Shape:SolidMolecular weight:776.44Alentemol hydrobromide
CAS:<p>Alentemol hydrobromide is a Dopamine agonist.</p>Formula:C19H26BrNOPurity:98%Color and Shape:SolidMolecular weight:364.32FMK-MEA
CAS:<p>FMK-MEA is a potent and selective p90 Ribosomal S6 Kinase (RSK) inhibitor.</p>Formula:C21H26FN5O2Purity:98%Color and Shape:SolidMolecular weight:399.46Tubulin inhibitor 13
CAS:<p>Tubulin inhibitor 13 (E27), IC50 16.1 μM, blocks tubulin polymerization, cancer cell migration, and invasion, induces apoptosis.</p>Formula:C25H21N3O4Color and Shape:SolidMolecular weight:427.45FGFR4-IN-10
<p>FGFR4-IN-10 (compound 5a) is a potent, selective FGFR4 inhibitor with IC50 of 70.7 nM, sparing FGFR1-3.</p>Formula:C20H19F3N6O3Color and Shape:SolidMolecular weight:448.4AMG-548 hydrochloride
<p>AMG-548 hydrochloride: orally active, p38α inhibitor (Ki=0.5 nM), 1000x less for p38γ/δ, also blocks TNFα (IC50=3 nM) & inhibits casein kinase 1 δ/ε.</p>Formula:C29H28ClN5OColor and Shape:SolidMolecular weight:498.02PD-1/PD-L1-IN-17
<p>PD-1/PD-L1-IN-17 (Compound P20) is a potent PD-1/PD-L1 inhibitor (IC50: 26.8 nM).</p>Formula:C23H20ClN3O4Color and Shape:SolidMolecular weight:437.88(1R,3S)-THCCA-Asn
<p>(1R,3S)-THCCA-Asn (4j) is a selective inhibitor of thrombin (IC50: 0.07-0.14 μM) with anti-thrombotic effects.</p>Formula:C24H24N4O6Color and Shape:SolidMolecular weight:464.47Anticancer agent 30
<p>Anticancer agent 30 (6f-Z), a 3-arylidene-2-oxindole, selectively inhibits CDK2, showing potent anticancer potential.</p>Formula:C22H15ClFNOColor and Shape:SolidMolecular weight:363.81Anti-inflammatory agent 19
<p>Anti-inflammatory agent 19: NO inhibitor (IC50: 36μM), blocks HMGB1, for late-stage inflammation, relevant for COVID-19, sepsis.</p>Formula:C30H50O7Color and Shape:SolidMolecular weight:522.71
